Related Experiment Video
Updated: Jun 5, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Effect of microtubule-targeting drugs on cell-cell and cell-matrix junctions in tumor epithelial cells
Laura Tonutti1, Elena Bononi, Luca Paris
1Mario Negri Institute of Pharmacological Research, Milano, Italy.
Abstract:
In this study, we investigated the effects of microtubule-targeting drugs, which either destabilize (the Vinca alkaloid vincristine) or stabilize (the taxane derivative docetaxel) microtubules, on the cell-cell and cell-matrix adhesive junctions of Caco-2 tumor epithelial cells, using fluorescence imaging and functional assays. We found that, in sub-confluent (but not confluent) cells, vincristine (but not docetaxel) affected cell-cell junction morphology. Furthermore, docetaxel (but not vincristine) attenuated the formation of the peri-junctional actomyosin ring and enhanced the internalization of junctional adhesion molecule-A. However, these effects of vincristine and docetaxel did not translate into appreciable functional changes during the opening and resealing of the cell-cell junctions. We also found that vincristine caused enlargement of focal adhesions (the major cell-matrix junctions) without affecting cell adhesion onto the matrix. Thus, we conclude that the microtubule-targeting drugs interfere to variable degrees with the morphology and/or function of the cell-cell and cell-matrix adhesive junctions. In addition, the results highlight the importance of considering the cellular context and dynamics (e.g. cell confluence and junction opening, respectively), when determining the final effects of microtubule manipulation on cell adhesiveness.
Insights
Microtubule-targeting drugs like vincristine and docetaxel impact cell junctions differently. Vincristine affects cell-cell junction shape, while docetaxel alters actomyosin rings and cell-matrix adhesion in Caco-2 cells.
Area of Science:
- Cell Biology
- Molecular Pharmacology
- Cancer Research
Background:
- Microtubules are crucial cytoskeletal components involved in cell structure and adhesion.
- Microtubule-targeting drugs are widely used in cancer chemotherapy.
- Understanding their effects on cell junctions is vital for predicting drug efficacy and side effects.
Purpose of the Study:
- To investigate how microtubule destabilizers (vincristine) and stabilizers (docetaxel) affect cell-cell and cell-matrix adhesion junctions.
- To determine the impact of these drugs on the morphology and function of adhesive junctions in Caco-2 epithelial cells.
Main Methods:
- Utilized fluorescence imaging to visualize changes in cell junctions.
- Employed functional assays to assess junctional integrity and cell adhesion.
- Examined Caco-2 tumor epithelial cells under varying conditions (sub-confluent vs. confluent).
Main Results:
- Vincristine altered cell-cell junction morphology in sub-confluent cells, while docetaxel affected the actomyosin ring and junctional adhesion molecule-A internalization.
- Neither drug caused significant functional changes in cell-cell junction opening or resealing.
- Vincristine led to focal adhesion enlargement without impacting cell-matrix adhesion.
Conclusions:
- Microtubule-targeting drugs differentially affect the morphology and function of cell-cell and cell-matrix adhesive junctions.
- Cellular context, such as cell confluence and junction dynamics, is critical in determining the effects of microtubule manipulation on cell adhesiveness.
More Related Videos
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Assembly of Complex Microtubule Structures
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Tumor Microenvironment

